PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING ST ...
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.436
https://www.valueinhealthjournal.com/article/S1098-3015(19)32814-1/fulltext
Title :
PCN241 COSTS OF CYTOKINE RELEASE SYNDROME (CRS) AND NEUROLOGICAL EVENTS (NE) IN PATIENTS WITH RELAPSED/REFRACTORY NON-HODGKIN LYMPHOMA RECEIVING LISOCABTAGENE MARALEUCEL (LISO-CEL) IN THE TRANSCEND NHL 001 CLINICAL TRIAL: A MICRO-COSTING ST ...
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32814-1&doi=10.1016/j.jval.2019.09.436
First page :
Section Title :
Open access? :
No
Section Order :
10360